AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04715516 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: lifestyle health promotion
Description: Lifestyle health promotion specific to physical activity and maintaining a healthy weight, developed to be relevant to women attending breast screening services, will be provided.
Study NCT05673239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levocarnitine Injection
Description: The patients in the test group were injected with 1-2g (10-20mg/kg) levocarnitine on each dialysis day
Study NCT05613790 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active High-Definition Transcranial Direct Current Stimulation (HD-tDCS)
Description: Portable multi-channel tES stimulation (Starstim 8, Neuroelectric, Barcelona, Spain) will be used.
Study NCT05613790 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham High-Definition Transcranial Direct Current Stimulation (HD-tDCS)
Description: Portable multi-channel tES stimulation (Starstim 8, Neuroelectric, Barcelona, Spain) will be used.
Study NCT05040555 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: R-CDOP
Description: Rituximab 375mg/m2, D0; Cyclophosphamide 750mg/ m2, D1; Doxorubicin hydrochloride liposome 30-35mg/ m2, D1; Vindesine 3mg/ m2, D1; Prednisone 60mg/ m2, D1\~5.
Study NCT04700501 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Enjoy Your Bump - CBT life skills learning programme
Description: Antenatal use of an online Cognitive Behavioural Therapy life skills learning programme to improve maternal feelings of anxiety and low mood.
Study NCT05403164 — intervention group
Intervention type: PROCEDURE
Intervention: Modified Widman flap
Description: 1. Administration of anaesthesia~2. First incision (reversed bevel incision), scalpel is placed at 45 degree, 2mm apical to gingival margin in coronal-apical direction until touching the bone and moved continuously around the teeth without any vertical releasing incisions~3. Partial mobilization of the mucoperiosteal flap (full thickness flaps both facially and orally) within the attached gingiva to the alveolar crest~4. Second incision (sulcular incision)~5. Third incision (horizontal incision), also interdentally to remove the delineated tissue and all granulation tissue which is used later for analysis.~6. Root surface debridement~7. Flap adaptation, complete coverage interdentally and suturing.
Study NCT05403164 — intervention group
Intervention type: PROCEDURE
Intervention: Gingivectomy
Description: 1. Administration of anaesthesia~2. Marking the base of the sulcus with pocket marker tweezer.~3. First incision (gingivectomy incision), scalpel blade placed 1mm apical to the bleeding points and the incision should be beveled 45 degrees coronally.~4. Second incision (interdental) to free the tissue which is used for analysis later.~5. Debriding the area and applying periodontal pack.
Study NCT04863625 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: a peer-led educational intervention based on theory of planned behavior on substance use intentions and behaviors
Description: The intervention will be a peer led education process on substance use (smoking, drinking and chewing) prevention based on the Theory of Planned Behavior (TPB).The intervention aims to encourage anti-substance attitudes and beliefs; foster perceptions of normative support for anti-substance behavior; increase perceptions of control/self-efficacy to resist substance use, increase knowledge and risk perceptions on substance and decrease in intention to use substance and actual substance use behaviors. Six education sessions will be delivered, with one session occurring each week. Each session will be lasted 40-55 minutes. The intervention will be conducted in 30 groups of selected students from grade 9-12, a pair of peer educators will educate a 30 sized group weekly (30 students /group)/ classrooms at pre-assigned time during class periods. The six sessions will be guided by four student training modules.
Study NCT05545891 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A drug that contains no medicine
Study NCT05545891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Description: Atypical antipsychotic medication
Study NCT05668169 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Family-centered support program for caregivers of stroke survivors
Description: Once participants joined the family-centered support group, participants received 90-minute interventions, including an introduction to stroke and rehabilitation education, problem-solving skills training, and long-term care information. Investigators also invited participants to join the instant messaging application-based 24-h peer-support group for caregivers. On the second and fourth days after receiving the interventions, the researcher visited the participants to review and practice the content provided on the first day; each session was 30 to 40 minutes long. The researcher contacted the participants one week after participants joined the study to discuss their care difficulties or experiences and did so three times biweekly thereafter via the instant messaging application.
Study NCT05151068 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: traditional nursing method
Description: ①Preoperative education, informing patients of the importance of the tube and the adverse effects of unauthorised extubation after the operation on the recovery of the disease. ②Pipe care: The nose wing is fixed with modified human elastic tape, and the same side cheek bridge is fixed to keep the duct unobstructed and pour gastric juice in time. ③Oral care: routinely brush teeth and gargle with mouthwash daily. ④Skin care: Observe the condition of the nose, cheek skin and oral and nasal mucosa. Replace the tape as needed, and clean the skin before fixing. ⑤ Pain care: assess the degree of pain, follow the doctor's prescription for medication, and observe the efficacy of medication. ⑥Psychological care: pay attention to the emotional changes of patients and provide psychological support.
Study NCT05151068 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precise acupoint application combined with ear acupoint embedding nursing program
Description: On the basis of conventional nursing, the experimental group adopted a precision nursing program of acupoint application combined with ear acupoint embedding.
Study NCT06463444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAIC + Tislelizumab +lenvatinib
Description: All patients were treated with HAIC combined with tislelizumab and lenvatinib.~1. HAIC was adopted of the FOFOLX 6 program, Folinic acid+5-fluorouracil+Oxaliplatin, 21 days between second HAIC treatments with a window of ±3 days.~2. Lenvatinib was started before HAIC treatment, discontinued during HAIC treatment, Oral 8 mg or 12mg once a day depending body weight.~3. First treatment with Tislelizumab was started 0-1 days after HAIC, 200 mg IV, followed by a second treatment 21 days later.
Study NCT05807113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Atopi intensive care BNO 3731
Description: Crem twice daily
Study NCT05807113 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Benchmark product
Description: Crem twice daily
Study NCT05980208 — intervention group
Intervention type: DRUG
Intervention: Inetetamab
Description: Inetetamab-based treatment for first-line treatment of HER2-positive MBC
Study NCT05093504 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham comparator
Description: Sham comparator in similar position to the investigational device, but NOT integrated into the cardiopulmonary bypass (CPB) circuit
Study NCT05093504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DrugSorb-ATR system
Description: Sorbent hemoperfusion system integrated into the cardiopulmonary bypass (CPB) circuit
Study NCT06086210 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low-level laser therapy
Description: Low-level laser therapy was applied to each area for 1 minute, with a wavelength of 808 nm and a dose of 2j/cm2 for a total of 5 minutes,10j/cm2 in continuous mode. A total of 15 sessions were applied 5 days a week for 3 weeks.
Study NCT06086210 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham therapy was applied to each area for 1 minute, with a wavelength of 0 nm and a dose of 0j/cm2 for a total of 5 minutes, 0j/cm2. A total of 15 sessions were applied 5 days a week for 3 weeks.
Study NCT05669131 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor imagery training
Description: Participants imagine themselves through their own eyes performing submaximal elbow flexion contractions.
Study NCT05284864 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stoma closure
Description: Stoma closure after rectal surgery
Study NCT05284864 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stoma closure
Description: Stoma closure after rectal surgery
Study NCT04826965 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wound Vac is applied
Description: A wound vac or wound vac with cleanse choice dressing, track pad duo, and saline irrigation is applied.
Study NCT06040190 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: topical placebo tablet
Description: Individuals will be instructed to dissolve half a tablet of placebo medication and hold the saliva near the painful oral sites without swallowing, for 3 minutes and then spit. Tablets will contain magnesium silicate, with the same color and flavor as the test medications. Researchers will provide a total of 32 tablets for each participant.
Study NCT06040190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topical clonazepam tablet
Description: Individuals will be instructed to dissolve half a tablet of clonazepam and hold the saliva near the painful oral sites without swallowing for 3 minutes and then spit. Researchers will provide a total of 32 tablets for each participant.
Study NCT06040190 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: oral alpha-lipoic acid capsule
Description: Participants in this group will be instructed to take oral capsules containing alpha-lipoic acid.
Study NCT06040190 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: topical phytotherapic capsaicin gel
Description: Participants in this group will to apply the gel containing tocapsaicin on painful oral sites.
Study NCT06040190 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: local photobiomodulation
Description: Photobiomodulation will be applied during 10 seconds per point at 56 points (three on the vestibular mucosa of the 4 quadrants, four on each labial mucosa, six on each of the two buccal mucosae, six on the hard palate, four on each lateral edge of the tongue, six on the dorsum of the tongue, and four sublingual points) with an intermediate distance of 2 mm. A dose of 12 J/cm² per session will be applied in continuous mode for 10 sessions. The 10 sessions will be applied twice a week for 5 consecutive weeks. The LASER will be applied perpendicularly in contact with the mucosa. All patients and the clinician will wear protective glasses.
Study NCT06517576 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blood glucose monitor with Digital Platform and Health Coaching
Description: Blood glucose monitors will be used daily to measure blood glucose measurements.
Study NCT06517576 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitor
Description: Continuous glucose monitors will be used daily to measure blood glucose measurements.
Study NCT06517576 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care for type 2 diabetes
Study NCT05578898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CLEAR Care Companion (CC) application
Description: The CLEAR CC application is an EPIC-based, electronic application, downloaded to the patient's Smartphone or Tablet. The CLEAR CC leverages patient-reported symptoms assessment vis-a-vis push notifications to complete clinically meaningful questions and validated questionnaires pertaining to symptoms that serve as early indicators of readmission. The CLEAR CC application will send notifications beginning two days prior to surgery and continue until the 6 week post operative appointment.
Study NCT04975269 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetazolamide
Description: Target dose: 500 mg / day
Study NCT04975269 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05934604 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI)
Description: Healthy subjects will complete two fMRI sessions after initial assessment and training in the Rest Focus Task (RFT). The first session will be the localizer session to identify the networks involved in switching in the RFT. The second fMRI session, real time functional magnetic resonance imaging neurofeedback (rtfMRI-NF) session, will use localizer information from the first fMRI session to develop a mask for the rtfMRI-NF, and deliver a neurofeedback (NF) stimulus while simultaneously measuring Blood Oxygenation Level Dependent (BOLD) activity for the STOP>RECALL contrast.
Study NCT04276116 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pulmonary age
Description: Communication of pulmonary age
Study NCT05839197 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HAIC
Description: administration of oxaliplatin , fluorouracil, and leucovorin via the tumor feeding arteries every 3 weeks.
Study NCT05839197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab plus Apatinib
Description: Apatinib(250 mg; p.o.; qd.); camrelizumab (200 mg; iv drip; q3w) If the liver function was grade Child-Pugh A, Camrelizumab was given intravenously once every 3 weeks (D1) on the same day, 200mg/, once every 3 weeks (D1).~Apatinib capsule was given orally to 250mg within half an hour after breakfast on the second day (D2) after the first HAIC. The drug was given continuously once a day and stopped on the same day of each HAIC.
Study NCT05396456 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Muscle Fiber Fragment (MFF) Injections
Description: The participant will be treated with an injection of muscle fiber fragments into the external anal sphincter at 3, 6, 9 and 12 o'clock using a 21-gauge needle to a depth of 1-2 cm from the external skin using equal amounts in each quadrant.
Study NCT04738747 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WHOOP fitness tracker
Description: WHOOP is a device that uses a wristband or arm band to track heart rate, heart rate variability (HRV), and sleep to calculate proprietary strain and recovery scores for its users. Heart rate variability is an important metric for correlation with acute stress
Study NCT06221202 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stories in the Moment Dance Program - Online
Description: Stories in the Moment is a co-creative dance, movement and storytelling program for persons living with dementia and care partners.
Study NCT05929677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants receive placebo (saline) intravenously. They will also have the opportunity to self-administer saline during the 60-minute free-access IV self-administration period in session 3.
Study NCT05929677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: Participants receive alcohol intravenously, clamped at BrACs of 20mg%, 40mg%, and 60mg%. They will also have the opportunity to self-administer alcohol (up to 120mg% BrAC) during the 60-minute free-access IV self-administration period in session 3.
Study NCT05620498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tislelizumab+lenvatinib+GMOX
Description: tislelizumab 200mg, Q3W Lenvatinib 4mg Po QD Gemcitabine 1g/m2 Oxaliplatin 100mg/m, D1, q3W2
Study NCT05620498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tislelizumab+GEMOX
Description: tislelizumab+GEMOX
Study NCT06065878 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IPACK + Genicular Nerve Block
Description: IPACK and Genicular Nerve block were applied with the same total volume of local anesthetic as the control group.
Study NCT06536192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Model group
Description: 1. Process: Theoretical knowledge will be given to students, and then different types of gynecological examinations will be explained practically on a model in the laboratory environment.~2. Process: The learner guide will be filled out.~3. Process: After 15 days, students will be taken back to the laboratory environment to fill out the learner guide again. In addition, SCS and SSSLS will be filled out for the last exam.
Study NCT05652621 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotics
Description: Resistant dextrin (water-soluble dietary fiber), Lactobacillus reuteri PLBK1, Luo Lactobacillus delbrueckii, Lactobacillus griffii PLBK3, Lactobacillus acidophilus PLBK4, Bifidobacterium lactis PLBK5）
Study NCT03949556 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Videos and/or SMS
Description: Participants assigned to one of the intervention programmes will watch videos on a website for two months then will receive SMSs for four months.
Study NCT03949556 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Videos and/or SMS
Description: Participants assigned to one of the intervention programmes will watch videos on a website for two months then will receive SMSs for four months.
Study NCT05519384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JK500 cell injection，cyclophosphamide，Fludarabine
Description: After enrollment, patients received JK500 cell injection infusion after reinduction therapy. Pretreatment regimen before cell infusion: intravenous infusion of cyclophosphamide 60mg/kg day -7, intravenous infusion of fludarabine 25mg/㎡/day day -6 to -2 days. In order to activate and expand circulating NK cells, on the day of each infusion of JK500 cells, the patients were first subcutaneously injected with 100WU/ m2 of interleukin (IL)-2 0.5h-1h in advance, for a total of 6 doses.
Study NCT03949556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Videos and/or SMS
Description: Participants assigned to one of the intervention programmes will watch videos on a website for two months then will receive SMSs for four months.
Study NCT05073653 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 68Ga-PSMA PET/CT
Description: Exploratory, Single-institution Study, Comparing 68Ga-GRP PET/CT Versus 68Ga-PSMA PET/CT in Patients Diagnosed With Prostate Cancer of Low and Intermediate Risk for Radical Prostatectomy
Study NCT05073653 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 68Ga-GRP PET/CT
Description: Exploratory, Single-institution Study, Comparing 68Ga-GRP PET/CT Versus 68Ga-PSMA PET/CT in Patients Diagnosed With Prostate Cancer of Low and Intermediate Risk for Radical Prostatectomy
Study NCT06046781 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: physical exercise
Description: The patients were randomized into 5 groups as control group, walking at 2 weeks, walking at 4 weeks, waist exercise at 2 weeks, waist exercise at 4 weeks.
Study NCT06046781 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physical exercise
Description: The patients were randomized into 5 groups as control group, walking at 2 weeks, walking at 4 weeks, waist exercise at 2 weeks, waist exercise at 4 weeks.
Study NCT04683822 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: Patients will attend telerehabilitation sessions
Study NCT05359419 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: aminolevulinic acid hydrochloride gel, 10%
Description: 10% ALA with Red Light
Study NCT05359419 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: aminolevulinic acid HCl topical solution, 20%
Description: 20% ALA with Blue Light
Study NCT05169918 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stabilization
Description: The progressive core stabilization exercise approach created by Kumar et al. will be used.~* Stage 1; Isolation and facilitation of target muscles~* Stage 2; Trunk stabilization training with increased load under static conditions~* Stage 3; Development of trunk stabilization during slow controlled movement of the lumbar spine.~* Stage 4 and 5; Lumbar stabilization during high speed and dexterous movements. The exercises will last 20-30 minutes in each sessions and twice a week for 10 weeks. The level of stage will be increased when the patients reach the aim of the stage where he/she is at. The duration of the each stage will change depending on the days the patients' need to achieve the aim of the level. For each level, at least four exercise is described.
Study NCT05169918 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization
Description: The progressive core stabilization exercise approach created by Kumar et al. will be used.~* Stage 1; Isolation and facilitation of target muscles~* Stage 2; Trunk stabilization training with increased load under static conditions~* Stage 3; Development of trunk stabilization during slow controlled movement of the lumbar spine.~* Stage 4 and 5; Lumbar stabilization during high speed and dexterous movements. The exercises will last 20-30 minutes in each sessions and twice a week for 10 weeks. The level of stage will be increased when the patients reach the aim of the stage where he/she is at. The duration of the each stage will change depending on the days the patients' need to achieve the aim of the level. For each level, at least four exercise is described.